Soleus Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Soleus Capital Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-820,638	Closed	-$9.33M	–	104
2023 Q4	$9.33M	Buy	+820,638	New	+$6.45M	1.04%	31
2020 Q4	–	Sell	-4,247	Closed	-$722K	–	82
2020 Q3	$722K	Buy	4,247 +1,158	+37%	+$167K	0.38%	52
2020 Q2	$512K	Sell	3,089 -44,004	-93%	-$6.86M	0.29%	55
2020 Q1	$5.45M	Buy	47,093 +34,773	+282%	+$4.89M	6.35%	4
2019 Q4	$1.82M	Buy	+12,320	New	+$1.87M	1.76%	23

Soleus Capital Management's HARP Position: Q1 2024 in Review

Soleus Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 820,638 shares — an estimated $9.33M sold.

Soleus Capital Management first reported a position in HARP in Q4 2019 and held it in 5 quarters. The position peaked at $9.33M in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Soleus Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Soleus Capital Management sold 820,638 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $9.33M.
Soleus Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Soleus Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $9.33M in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Soleus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.